This report is a comprehensive business tool designed to provide an in-depth look at drugs for the congestive heart failure market. The geographic scope of the report is global with a special emphasis on individual regions. The report describes the industry, its relationship to the healthcare industry and its participants, and trends for the future.

1. Drugs for Treating Congestive Heart Failure: Global Markets
Published:October 2011
No.Of Pages:184
Price:US $ 4850
INTRODUCTION
STUDY GOALS AND OBJECTIVES
The objectives of the study are to present a comprehensive look at the drugs for treating
congestive heart failure (CHF)—global market measurements of both the overall market and
all possible market segments, and to forecast market and segment growth during the next
five years.
REASONS FOR STUDY
This BCC study will increase the awareness of drugs to treat congestive heart failure. The
study analyzes the global market for select drugs for treating the congestive heart failure. It
does so from different standpoints and addresses issues and trends affecting the market.
Congestive heart failure drug manufacturers, driven by both research breakthroughs and
increased recognition of expanding market opportunities, have stepped up the pace of
development of innovative products. Because of the evolving nature of this important area
of study, executives of product development for congestive heart failure drugs must remain
ever vigilant of the changing environment and strive to keep abreast of new and currently
used modalities in all facets of the market.
SCOPE OF STUDY
This report is a comprehensive business tool designed to provide an in-depth look at drugs
for the congestive heart failure market. The geographic scope of the report is global with a
special emphasis on individual regions. The report describes the industry, its relationship to
the healthcare industry and its participants, and trends for the future.
Categories discussed in the report include:
* Angiotensin converting enzyme (ACE) inhibitors/angiotensin II receptor blocker
antagonists (ARBs)
* Beta-adrenergic receptor blocking agents
* Diuretics
* Inotropic drugs/vasodilators
All categories are discussed in detail, describing each segment, identifying current products
on the market, measuring market size, identifying market drivers, forecasting for 2010 to
2016, and assessing the competitors and competitor market shares.

2. METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this study. The
information and analysis presented in this BCC report are based on extensive first-hand
interviews with primary research sources, including executives, product managers, and
clinical specialists in the congestive heart failure drug development arena. Background
information was obtained from various government agencies, business and medical
journals, trade magazines, and interviews with doctors and nurses involved in the treatment
of congestive heart failure.
Key information from published literature was used to conduct interviews with more than 20
industry participants to validate and obtain expert opinions on current and future trends in
the congestive heart failure drug market. Interviews were the primary basis for
development of market size. Interviews were also used to confirm and/or adjust market size
and market share estimates, as well as formulating market projections.
All market data pertain to the global market at the manufacturer’s level. Data are expressed
in current U.S. dollars. The base year was 2011. Historical data are provided for 2010 and
forecast data are provided for 2016. Historical, base year, and forecast data are provided
for each market segment and subsegment. Market shares are provided for each market
segment for the 2011 base year.
ANALYST CREDENTIALS
Mary Anne Crandall is an expert industry analyst specializing in the pharmaceutical industry
for the last 20 years. She has completed several in-depth studies on various medical topics
requiring both medical expertise and excellent knowledge of the pharmaceutical industry.
Ms. Crandall has extensive knowledge in the medical field, has an M.S. in psychology, and is
currently working on a PhD.
Table Of Contents
Chapter- 1: INTRODUCTION - Complimentary
STUDY GOALS AND OBJECTIVES
REASONS FOR STUDY
SCOPE OF STUDY
METHODOLOGY AND INFORMATION SOURCES
ANALYST CREDENTIALS
RELATED BCC REPORTS
BCC ONLINE SERVICES
DISCLAIMER
Chapter- 2: EXECUTIVE SUMMARY
Table : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHF PHARMACEUTICALS,
THROUGH 2016
Figure GLOBAL SUMMARY FIGURE : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHF
PHARMACEUTICALS, 2010–2016
Chapter- 3: OVERVIEW

3. ETIOLOGY
COMPENSATION
CLINICAL PRESENTATION OF CHF
DEMOGRAPHICS
TREATMENTS
PRODUCTS
RESEARCH AND DEVELOPMENT
Chapter- 4: THE GLOBAL MARKET
GROWTH BY GEOGRAPHIC REGION
GROWTH BY DRUG CLASS
COMPETITIVE ANALYSIS
Table 14 : GLOBAL CHF PHARMACEUTICAL MARKET BY COMPANY, 2011
Figure 7 : GLOBAL CHF PHARMACEUTICAL MARKET SHARES BY COMPANY, 2011
Table 15 : GLOBAL CHF MANUFACTURER PRODUCT PARTICIPATION BY DRUG TYPE
Chapter- 5: THE AMERICAS MARKET
REGIONAL MARKETS
CHF POPULATION
REGIONAL DEMOGRAPHICS
AMERICAS CHF MARKET FORECAST
Table 27 : AMERICAS CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION, THROUGH
2016
Figure 8 : AMERICAS CHF MARKET BY GEOGRAPHIC REGION, 2011
Table 28 : AMERICAS CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 29 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 9 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011
Table 30 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016
Figure 10 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016
Table 31 : U.S. CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 32 : CANADIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 33 : LATIN AMERICAN/SOUTH AMERICAN CHF MARKET BY DRUG TYPE, THROUGH
2016
Chapter- 6: THE EUROPEAN MARKET
REGIONAL MARKETS
REGIONAL DEMOGRAPHICS
EUROPEAN MARKET FORECAST
Table 40 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION,
THROUGH 2016
Figure 11 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2011
Figure 12 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2016
Table 41 : EUROPEAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 42 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011
Figure 13 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011
Table 43 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016
Figure 14 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016
Table 44 : CHF MARKET IN FRANCE BY DRUG TYPE, THROUGH 2016
Table 45 : CHF MARKET IN GERMANY BY DRUG TYPE, THROUGH 2016
Table 46 : CHF MARKET IN ITALY BY DRUG TYPE, THROUGH 2016
Table 47 : CHF MARKET IN SPAIN BY DRUG TYPE, THROUGH 2016

4. Table 48 : U.K. CHF MARKET BY DRUG TYPE, THROUGH 2016
Chapter- 7: THE ASIAN MARKET
DEMOGRAPHICS
REGIONAL MARKETS
ASIAN CHF MARKET FORECAST
Table 52 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, THROUGH 2016
Figure 15 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2011
Figure 16 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2016
Table 53 : ASIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 54 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 17 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011
Table 55 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016
Figure 18 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016
Table 56 : JAPAN’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 57 : CHINA’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Chapter- 8: REST-OF-WORLD/EMERGING MARKETS
REGIONAL DEMOGRAPHICS
REGIONAL MARKETS
ROW MARKET FORECAST
Chapter- 9: COMPANY PROFILES
ABBOTT LABORATORIES
ARCA BIOPHARMA
ASTRAZENECA
AUROBINDO PHARMA
BAYER AG
BIOHEART, INC.
BOEHRINGER INGELHEIM GMBH
BRISTOL-MYERS SQUIBB CO.
CARDIOKINE, INC.
DR. REDDY’S LABORATORIES, LTD.
FOREST LABORATORIES, INC.
GLAXOSMITHKLINE
MERCK
MITSUBISHI TANABE PHARMA CORP.
MYLAN, INC.
NEUROCRINE BIOSCIENCES
NOVARTIS
PFIZER, INC.
SANOFI-AVENTIS, INC.
SERVIER
SHIONOGI & CO., LTD.
TAKEDA PHARMACEUTICALS CO., LTD.
TEVA
Chapter- 10: APPENDIX: DIRECTORY OF COMPANIES
List of Tables

5. Summary Table : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHF
PHARMACEUTICALS, THROUGH 2016
Table 1 : TOTAL GLOBAL POPULATION BY SELECTED GEOGRAPHIC REGION, 2000–2050
Table 2 : SELECTED ACE INHIBITORS AVAILABLE FOR THE TREATMENT OF CHF
Table 3 : SELECTED ANGIOTENSIN II RECEPTOR BLOCKERS AVAILABLE FOR THE
TREATMENT OF CHF
Table 4 : SELECTED BETA-ADRENERGIC RECEPTOR BLOCKING AGENTS AVAILABLE FOR
THE TREATMENT OF CHF
Table 5 : SELECTED DIURETIC AGENTS AVAILABLE FOR TREATMENT OF CHF
Table 6 : SELECTED POSITIVE INOTROPIC DRUGS AVAILABLE FOR THE TREATMENT OF CHF
Table 7 : SELECTED VASODILATORS AVAILABLE FOR THE TREATMENT OF CHF
Table 8 : PRODUCTS IN DEVELOPMENT TO TREAT CHF
Table 9 : GLOBAL MARKET FORECAST FOR CHF PHARMACEUTICALS BY REGION, THROUGH
2016
Table 10 : GLOBAL MARKET SHARES OF CHF PHARMACEUTICAL REVENUES BY REGION,
2011
Table 11 : GLOBAL CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 12 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2011
Table 13 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2016
Table 14 : GLOBAL CHF PHARMACEUTICAL MARKET BY COMPANY, 2011
Table 15 : GLOBAL CHF MANUFACTURER PRODUCT PARTICIPATION BY DRUG TYPE
Table 16 : CHF POPULATION IN THE AMERICAS BY COUNTRY, 2011
Table 17 : U.S.’ OLDER POPULATION BY AGE GROUP & CENSUS YEAR, 2000–2050
Table 18 : CANADA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 19 : BRAZIL’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 20 : MEXICO’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2010
Table 21 : VENEZUELA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–
2050
Table 22 : ARGENTINA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–
2050
Table 23 : PERU’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 24 : CHILE’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 25 : COLOMBIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–
2050
Table 26 : CUBA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 27 : AMERICAS CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION, THROUGH
2016
Table 28 : AMERICAS CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 29 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011
Table 30 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016
Table 31 : U.S. CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 32 : CANADIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 33 : LATIN AMERICAN/SOUTH AMERICAN CHF MARKET BY DRUG TYPE, THROUGH
2016
Table 34 : EUROPEAN CHF POPULATION BY COUNTRY, 2011
Table 35 : FRANCE’S OLDER POPULATION BY AGE AND YEAR, 2000–2050
Table 36 : GERMANY’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 37 : ITALY’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 38 : SPAIN’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 39 : U.K.’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 40 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION,

6. THROUGH 2016
Table 41 : EUROPEAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 42 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011
Table 43 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016
Table 44 : CHF MARKET IN FRANCE BY DRUG TYPE, THROUGH 2016
Table 45 : CHF MARKET IN GERMANY BY DRUG TYPE, THROUGH 2016
Table 46 : CHF MARKET IN ITALY BY DRUG TYPE, THROUGH 2016
Table 47 : CHF MARKET IN SPAIN BY DRUG TYPE, THROUGH 2016
Table 48 : U.K. CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 49 : ASIAN CHF POPULATION BY COUNTRY, 2011
Table 50 : JAPAN’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 51 : CHINA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 52 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, THROUGH 2016
Table 53 : ASIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 54 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011
Table 55 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016
Table 56 : JAPAN’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 57 : CHINA’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 58 : THE REST OF THE WORLD’S CHF POPULATION BY COUNTRY, 2011
Table 59 : AUSTRALIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–
2050
Table 60 : INDIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 61 : ISRAEL’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 62 : RUSSIA’S OLDER POPULATION BY AGE GROUP AND CENSUS YEAR, 2000–2050
Table 63 : REST OF WORLD CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION,
THROUGH 2016
Table 64 : REST OF WORLD CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 65 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2011
Table 66 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2016
Table 67 : AUSTRALIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 68 : INDIA’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 69 : ISRAEL/THE MIDDLE EAST’S CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 70 : RUSSIAN CHF MARKET BY DRUG TYPE, THROUGH 2016
Table 71 : OTHER CHF MARKETS BY DRUG TYPE, THROUGH 2016
List of Figures
Summary Figure : TOTAL GLOBAL MARKET SIZE AND FORECAST FOR CHF
PHARMACEUTICALS, 2010–2016
Figure 1 : TOTAL GLOBAL POPULATION BY SELECTED GEOGRAPHIC REGION, 2000–2050
Figure 2 : GLOBAL MARKET FORECAST FOR CHF PHARMACEUTICALS BY REGION, 2010–
2016
Figure 3 : GLOBAL MARKET SHARES OF CHF PHARMACEUTICAL REVENUES BY REGION,
2011
Figure 4 : GLOBAL CHF MARKET BY DRUG TYPE, 2010-2016
Figure 5 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 6 : GLOBAL CHF MARKET SHARES BY DRUG TYPE, 2016
Figure 7 : GLOBAL CHF PHARMACEUTICAL MARKET SHARES BY COMPANY, 2011
Figure 8 : AMERICAS CHF MARKET BY GEOGRAPHIC REGION, 2011
Figure 9 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 10 : AMERICAS CHF MARKET SHARES BY DRUG TYPE, 2016

7. Figure 11 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2011
Figure 12 : EUROPEAN CHF PHARMACEUTICALS MARKET BY GEOGRAPHIC REGION, 2016
Figure 13 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2011
Figure 14 : EUROPEAN MARKET SHARES OF CHF PHARMACEUTICALS BY TYPE, 2016
Figure 15 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2011
Figure 16 : ASIAN CHF MARKET BY GEOGRAPHIC REGION, 2016
Figure 17 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 18 : ASIAN CHF MARKET SHARES BY DRUG TYPE, 2016
Figure 19 : REST OF WORLD CHF PHARMACEUTICAL MARKET BY GEOGRAPHIC REGION,
2010-2016
Figure 20 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2011
Figure 21 : REST OF WORLD CHF MARKET SHARES BY DRUG TYPE, 2016
About Us:
ReportsnReports is an online library of over 100,000+ market research reports and in-depth
market research studies & analysis of over 5000 micro markets. We provide 24/7 online and
offline support to our customers. Get in touch with us for your needs of market research
reports.
Follow us on Twitter: http://twitter.com/marketsreports
Our Facebook Page: http://www.facebook.com/pages/ReportsnReports/191441427571689
Contact:
Mr.Priyank
7557 Rambler road,
Suite727,Dallas,TX75231
Tel: + 1 888 391 5441
E-mail: sales@reportsandreports.com
http://www.reportsnreports.com
Visit our Market Research Blog